Mining Industry Expansion Fuels The Prevalence Of Black Lung Disease Driver: A Major Catalyst in the Evolution of the Black Lung Disease Market in 2025

What industry-specific factors are fueling the growth of the black lung disease market?
The upward trend in mining activities is likely to fuel the expansion of the black lung disease market. Mining entails the extraction of precious minerals, ores, and other earth materials, which can cause black lung disease due to inhalation of dangerous carbon particles present in coal dust. For example, the International Energy Agency, a French intergovernmental agency, reported in July 2023 that there was a significant 30% growth in critical mineral production, hitting $41 billion in 2022, following a 20% rise in 2021. Over the previous five years, the demand for these minerals has grown significantly, with lithium consumption tripling and cobalt demand increasing by 70%. Therefore, the uptick in mining activities is a major driving factor for the black lung disease market. Increasing numbers of tuberculosis cases are also contributing to the growth of the black lung disease market. Tuberculosis, primarily caused by Mycobacterium tuberculosis, is an airborne bacterial infection with symptoms like cough, fever, weight loss, and fatigue. Individuals with tuberculosis are more likely to contract black lung disease due to higher exposure to coal dust. According to the Centers for Disease Control and Prevention, a national public health organization based in the U.S, tuberculosis cases in the country increased to 8,300 in 2022 from 7,874 in 2021. Therefore, the surge in tuberculosis prevalence is playing a vital role in the growth of the black lung disease market.

Get Your Black Lung Disease Market Report Here:
https://www.thebusinessresearchcompany.com/report/black-lung-disease-global-market-report

What Is the projected market size and growth rate for the black lung disease market?
The market size for black lung disease has experienced quick expansion in the past few years, increasing from $9.66 billion in 2024 to an estimated $11.02 billion in 2025 at a compound annual growth rate (CAGR) of 14.1%. Factors contributing to this growth during the historic period include developments in the coal mining sector, increased awareness and education about the disease, enhancements in compensation and benefits for patients, and advancements made in legislative and legal avenues.

The market for black lung disease is anticipated to experience swift expansion in the coming years, escalating to a value of $19.42 billion by 2029 with a compound annual growth rate (CAGR) of 15.2%. The projected upsurge during the forecast period can be linked to factors such as public health strategies, advancements in medicine, a rise in treatment alternatives, and the support from advocacy organizations. Key trends during the forecast period are expected to involve sophisticated diagnostic methods, research, prevention measures, accessibility to healthcare, and technological progress.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12988&type=smp

What major market segments define the scope and growth of the black lung disease market?
The black lung disease market covered in this report is segmented -

1) By Type: Simple Coal Worker's Pneumoconiosis, Complicated Coal Worker's Pneumoconiosis, Other Types
2) By Treatment: Oxygen Therapy, Bronchodilators, Lung Transplant, Stem Cell Therapy, Other Treatment
3) By Diagnosis: Biopsy, Imaging, Full Blood Count, Pulmonary Or Lung Function Tests, Physical Examination, Other Diagnosis
4) By End Users: Hospitals And Clinics, Research Organizations And Academic Institutes, Diagnostic Centers And Labs, Other End Users

Subsegments:
1) By Simple Coal Worker's Pneumoconiosis: Asymptomatic Simple Pneumoconiosis, Symptomatic Simple Pneumoconiosis
2) By Complicated Coal Worker's Pneumoconiosis: Progressive Massive Fibrosis (PMF), Complicated Pneumoconiosis With Respiratory Symptoms
3) By Other Type: Mixed Dust Pneumoconiosis, Other Related Respiratory Diseases

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12988

Which region dominates the black lung disease market?
North America was the largest region in the black lung disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in black lung disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which key market leaders are driving the black lung disease industry growth?
Major companies operating in the black lung disease market are Pfizer Inc., Johnson and Johnson, Siemens AG, General Electric, F. Hoffmann-La Roche AG, Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Melinta Therapeutics LLC, GlaxoSmithKline PLC, Medtronic PLC, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Toshiba Corporation, Koninklijke Philps N.V., Mayo Clinic, Baxter International Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Lab India Pvt. Ltd., Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Lupin Limited.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12988&type=smp

What Is Covered In The Black Lung Disease Global Market Report?

• Market Size Forecast: Examine the black lung disease market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the black lung disease market for a structured understanding.
• Key Players Overview: Analyze major players in the black lung disease market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the black lung disease market.
• Segment Contributions: Evaluate how different segments drive overall growth in the black lung disease market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the black lung disease market.
• Industry Challenges: Identify potential risks and obstacles affecting the black lung disease market.
• Competitive Landscape: Review strategic developments in the black lung disease market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.